Reply to: Biological Therapy in Patients with Rheumatoid Arthritis in a Tertiary Center in Portugal: A Cross-Sectional Study

Reply to: Biological Therapy in Patients with Rheumatoid Arthritis in a Tertiary Center in Portugal: A Cross-Sectional Study

N/a.

Bibliographic Details
Main Authors:	Joana Ramos Rodrigues, Daniela Santos-Faria, Carmo Afonso, José Tavares-Costa
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2021-06-01
Series:	Acta Médica Portuguesa
Subjects:	arthritis, rheumatoid/drug therapy biological products/therapeutic use biological therapy
Online Access:	https://actamedicaportuguesa.com/revista/index.php/amp/article/view/16513

Similar Items

Biological Therapy in Patients with Rheumatoid Arthritis in a Tertiary Center in Portugal: A Cross-Sectional Study
by: Melissa Fernandes, et al.
Published: (2021-05-01)

Biologic therapy of rheumatoid arthritis
by: Damjanov Nemanja, et al.
Published: (2009-01-01)

Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
by: Findeisen KE, et al.
Published: (2021-08-01)

THE PLACE OF TOFACITINIB IN THE TREATMENT STRATEGY OF RHEUMATOID ARTHRITIS
by: V. I. Mazurov, et al.
Published: (2018-05-01)

Pre-treatment antinuclear antibody positivity, therapeutic efficacy and persistence of biologics in rheumatoid arthritis
by: Codreanu Cătălin, et al.
Published: (2016-06-01)

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
by: Marta Novella-Navarro, et al.
Published: (2020-12-01)

Studying Cytokine Profile in Patients with Juvenile Rheumatoid Arthritis During Biological Therapy
by: Ya.Ye. Boyko, et al.
Published: (2014-08-01)

Princípios gerais do tratamento da artrite reumatoide inicial General principles for treatment of early rheumatoid arthritis
by: Licia Maria Henrique da Mota, et al.
Published: (2010-01-01)

Association Between the Extent of Periodontal Inflammation and the Severity of Rheumatoid Arthritis in Japanese Patients With Rheumatoid Arthritis
by: Hiroko Hashimoto, et al.
Published: (2021-10-01)

THE EFFECT OF ABATACEPT ON BLOOD BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-09-01)

Relationship between Tooth Loss and the Medications Used for the Treatment of Rheumatoid Arthritis in Japanese Patients with Rheumatoid Arthritis: A Cross-Sectional Study
by: Hiroko Hashimoto, et al.
Published: (2021-02-01)

Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
by: Yinzhu Jin, et al.
Published: (2017-07-01)

Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
by: Bolge SC, et al.
Published: (2016-06-01)

Effect of biological treatment on the daily functioning of patients with rheumatoid arthritis
by: Miriam Miedziak, et al.
Published: (2017-08-01)

Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity
by: Kichul Shin, et al.
Published: (2020-01-01)

Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
by: Vasco C. Romão, et al.
Published: (2017-10-01)

EULAR recommendations for the management of rheumatoid arthritis: what is new in 2017 and its applicability in our local setting
by: Mok Chi Chiu
Published: (2017-11-01)

Renal disease in patients with rheumatoid arthritis treated with biological therapy
by: Hanzu-Pazara Loredana, et al.
Published: (2016-02-01)

MODERN VIEWS ON PATHOGENETIC THERAPY OF RHEUMATOID ARTHRITIS
by: D. G. Rekalov, et al.
Published: (2013-12-01)

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients
by: María Ángeles González-Fernández, et al.
Published: (2019-01-01)

Use of biological therapy in patients with rheumatoid arthritis in the Republic of Kazakhstan
by: M G Nogaeva, et al.
Published: (2015-08-01)

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study
by: Yusuke Miyazaki, et al.
Published: (2021-06-01)

Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
by: D. A. M. Thuy Trang, et al.
Published: (2021-08-01)

Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
by: N. V. Chebotareva, et al.
Published: (2020-06-01)

First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study
by: Paula Muilu, et al.
Published: (2020-07-01)

Ultrasound of the hand is sufficient to detect subclinical inflammation in rheumatoid arthritis remission: a post hoc longitudinal study
by: Hilde Berner Hammer, et al.
Published: (2017-10-01)

Cost-Effectiveness Analysis of Etanercept in Combination with Methotrexate for Rheumatoid Arthritis - Markov Model Based on Data from Serbia
by: Kostic Marina
Published: (2017-12-01)

Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis
by: Mathieu Ferrari, et al.
Published: (2021-02-01)

Identifying the association between health care resource utilization and switching of biologics in rheumatoid arthritis
by: Lu, Jackie Yu-Chen
Published: (2014)

Rheumatoid arthritis
by: Yoshiya Tanaka
Published: (2020-09-01)

Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
by: Edit Végh, et al.
Published: (2021-04-01)

Updated Greek Rheumatology Society Guidelines for the Management of Rheumatoid Arthritis
by: Dimitrios Vassilopoulos, et al.
Published: (2020-01-01)

Infliximab in the therapy of rheumatoid arthritis
by: G. V. Lukina, et al.
Published: (2016-05-01)

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AS A COMPLICATION OF RITUXIMAB THERAPY FOR RHEUMATOID ARTHRITIS (A CASE REPORT)
by: I. B. Bashkova, et al.
Published: (2018-09-01)

Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
by: George E. Fragoulis, et al.
Published: (2019-10-01)

CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA
by: Elena Lvovna Luchikhina
Published: (2009-09-01)

Cost-effectiveness analysis of tocilizumab in combination with methotrexate for rheumatoid arthritis: A Markov model based on data from Serbia, country in socioeconomic transition
by: Kostić Marina, et al.
Published: (2014-01-01)

Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study
by: Sung Won Lee, et al.
Published: (2019-09-01)

Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
by: Masahiro Tachibana, et al.
Published: (2020-07-01)

Patient-reported fatigue in patients with rheumatoid arthritis who commence biologic therapy: a longitudinal study
by: Hege Selheim Rinke, et al.
Published: (2019-04-01)